U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.686del (p.Gly229fs) AND Maturity-onset diabetes of the young type 2

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 10, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003987576.1

Allele description [Variation Report for NM_000162.5(GCK):c.686del (p.Gly229fs)]

NM_000162.5(GCK):c.686del (p.Gly229fs)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.686del (p.Gly229fs)
HGVS:
  • NC_000007.14:g.44147829del
  • NG_008847.2:g.55344del
  • NM_000162.5:c.686delMANE SELECT
  • NM_001354800.1:c.686del
  • NM_033507.3:c.689del
  • NM_033508.3:c.683del
  • NP_000153.1:p.Gly229fs
  • NP_001341729.1:p.Gly229fs
  • NP_277042.1:p.Gly230fs
  • NP_277043.1:p.Gly228fs
  • LRG_1074t1:c.686del
  • LRG_1074t2:c.689del
  • LRG_1074:g.55344del
  • LRG_1074p1:p.Gly229fs
  • LRG_1074p2:p.Gly230fs
  • NC_000007.13:g.44187428del
  • NM_000162.5:c.686delGMANE SELECT
Protein change:
G228fs
Links:
dbSNP: rs1554335164
NCBI 1000 Genomes Browser:
rs1554335164
Molecular consequence:
  • NM_000162.5:c.686del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354800.1:c.686del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_033507.3:c.689del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_033508.3:c.683del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Maturity-onset diabetes of the young type 2
Synonyms:
MODY type 2; Diabetes mellitus MODY type 2; MODY glucokinase-related; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007453; MedGen: C0342277; Orphanet: 552; OMIM: 125851

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004804346Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Jan 10, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Analysis of the GCK gene in 79 MODY type 2 patients: A multicenter Turkish study, mutation profile and description of twenty novel mutations.

Aykut A, Karaca E, Onay H, Gökşen D, Çetinkalp Ş, Eren E, Ersoy B, Çakır EP, Büyükinan M, Kara C, Anık A, Kırel B, Özen S, Atik T, Darcan Ş, Özkınay F.

Gene. 2018 Jan 30;641:186-189. doi: 10.1016/j.gene.2017.10.057. Epub 2017 Oct 19.

PubMed [citation]
PMID:
29056535

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004804346.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: GCK c.686delG (p.Gly229AlafsX65) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 250196 control chromosomes (gnomAD). c.686delG has been reported in the literature in at least one individual affected with Maturity Onset Diabetes Of The Young 2 (e.g., Aykut_2018). These data suggest the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication was ascertained in the context of this evaluation (PMID: 29056535). ClinVar contains an entry for this variant (Variation ID: 447414). Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024